← Back to Influence Map
Entity DossierOrganization
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
DC · US
Trade association of innovative biopharmaceutical research companies.
farapharmaceuticals
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$54,330,000
Connections
18
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$75.2MTRDTrade
$75.1MMMMMedicare/Medicaid
$75.0MCPTCopyright/Patent/Trademark
$74.9MBUDBudget/Appropriations
$74.8MPHAPharmacy
$360KDEFDefense
$180KTAXTaxation/Internal Revenue Code
$50KCSPConsumer Protection
$50KLobbying Firms Retained
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA$74.3M
CROSSROADS STRATEGIES, LLC$450K
DLA PIPER LLP (US)$180K
MARSHALL & POPP, LLC$120K
AKIN GUMP STRAUSS HAUER & FELD$120K
EMPIRE CONSULTING GROUP$100K
AEGIS LLC$60K
Public Strategies Washington$50K
LMH STRATEGIC SOLUTIONS$0
Bills Referenced in Lobbying Filings
S. 832PBMmarch-ininsulinUkraine supplementalH.R. 8333
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | AKIN GUMP STRAUSS HAUER & FELD | Hired AKIN GUMP STRAUSS HAUER & FELD to lobby on PBM Reform Act | Source |
| Lobbied for | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $50,000 | Source |
| Employed by | EMPIRE CONSULTING GROUP | Hired EMPIRE CONSULTING GROUP to lobby on Insulin Price Caps | Source |
| Employed by | Public Strategies Washington | Hired PUBLIC STRATEGIES WASHINGTON, INC. to lobby on Pharmaceuticals | Source |
| Employed by | DLA PIPER LLP (US) | Hired DLA PIPER LLP (US) to lobby on Pharmaceuticals | Source |
| Employed by | CROSSROADS STRATEGIES, LLC | Hired CROSSROADS STRATEGIES, LLC to lobby on Pharmaceuticals | Source |
| Employed by | LMH STRATEGIC SOLUTIONS | Hired LMH STRATEGIC SOLUTIONS to lobby on Pharmaceuticals | Source |
| Employed by | AEGIS LLC | Hired AEGIS LLC to lobby on Pharmaceuticals | Source |
| Employed by | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on Pharmaceuticals | Source |
| Lobbied for | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $40,000 | Source |
| Lobbied for | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Lobbied for | BIOSECURE Act (H.R.8333/S.3558) | LDA filing: lobbied on BIOSECURE Act, period 4th Quarter (Oct 1 - Dec 31), reported amount $7,560,000 | Source |
| Lobbied for | Ukraine Security Assistance Supplemental | LDA filing: lobbied on Ukraine Security Supplemental, period 1st Quarter (Jan 1 - Mar 31), reported amount $7,990,000 | Source |
| Lobbied for | Sugar Reform Act (S.832, 118th Congress) | LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $12,880,000 | Source |
| commented_on | Federal Trade Commission | Public comment on FTC-2023-0040: Premerger Notification; Reporting and Waiting Period Requirements | Source |
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-0058: Transparency in Coverage CMS-9882-P | Source |
| Lobbied for | Action to Delay Effective Date Consistent With Congressionally Enacted Moratorium | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |
| Lobbied for | Rights to Federally Funded Inventions and Licensing of Government Owned Inventions | Lobbied on march-in — matched LDA filing topic to Federal Register rule. | Source |